LES BioPharmaceutical Royalty Rates and Deal Terms Survey Report

This valuable new report, developed by LES USA and Canada, provides important benchmark data on over 150 recent licensing deals in a range of therapeutic areas. The full report includes over 100 pages of charts and data on the prevailing royalty rates, milestone payments, and other key deal terms.

For a complete report of the Royalty Rate Survey click the button below:

Search LESI

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors